Predict your next investment

Corporation
HEALTHCARE | Medical Information
imshealth.com

See what CB Insights has to offer

Stage

Merger | Merged

Revenue

$0000 

About IMS Health

IMS Health (NYSE:IMS) is a worldwide provider of information, technology, and services to clients in the healthcare industry. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health, and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers, and the financial community. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications, and other services.

IMS Health Headquarter Location

83 Wooster Heights Road

Danbury, Connecticut, 06810,

United States

203-48-4600

Latest IMS Health News

IQVIA Named to FORTUNE’s 2021 List of “World’s Most Admired Companies”

Feb 1, 2021

February 01, 2021 08:00 AM Eastern Standard Time DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has been named to FORTUNE magazine’s “World’s Most Admired Companies” list. IQVIA has received this distinction every year, following the merger between IMS Health and Quintiles in 2016. IQVIA is recognized in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks regarding efficient use of corporate assets, management quality, effectiveness in conducting business globally and long-term investment value. “For the fourth consecutive year, IQVIA is privileged to be on FORTUNE’s list of the World’s Most Admired Companies. With all the challenges resulting from the global COVID-19 pandemic, this distinction reinforces and recognizes the innovation and drive of our 75,000 employees globally. Their work is critical to helping our clients advance the development and accessibility of innovative medical treatments that improve healthcare outcomes for patients around the world,” said IQVIA Chairman and CEO Ari Bousbib. FORTUNE’s World's Most Admired Companies list is the definitive report card on corporate reputation. Since 1997, FORTUNE has identified, selected and ranked the World’s Most Admired Companies, identifying the business practices that make these companies highly regarded among their peers. Most Admired Company Survey Methodology FORTUNE collaborated with Korn Ferry on this survey of corporate reputation. They began with a universe of about 1,500 organizations comprising the 1,000 largest U.S. companies ranked by revenue, along with non-U.S. companies from FORTUNE’s Global 500 database that have revenues of $10 billion or more. The list was then winnowed to the highest-revenue companies within each industry, a total of 680 across 30 countries, and the top-rated companies were picked from that pool. To determine the best-regarded companies spanning 52 industries, Korn Ferry asked executives, directors and analysts to rate enterprises within their own industry on nine criteria, from investment value and quality of management and products to social responsibility and ability to attract talent. A company must score in the top half of its industry peer group to be listed. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 75,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com . IQVIAFIN

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

IMS Health Patents

IMS Health has filed 55 patents.

The 3 most popular patent topics include:

  • Anisolabididae
  • Artificial intelligence
  • Artificial neural networks
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/29/2017

4/27/2021

Laser applications, Fiber optics, Optical devices, Spectroscopy, Laser science

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/29/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/27/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Laser applications, Fiber optics, Optical devices, Spectroscopy, Laser science

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.